Morgan Stanley raised the firm’s price target on Ameriprise to $365 from $360 and keeps an Equal Weight rating on the shares. This quarter, results from the Life/Annuity group showed sizable dispersion between the companies, but in aggregate both earnings and capital were stronger than expected, which bodes well for strong relative outperformance from the sector, the analyst tells investors in group recap note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AMP: